期刊文献+

环孢菌素A体内作用2h对淋巴细胞亚群的影响 被引量:1

Two Hours Effects of Cyclosporin A on Lymphocyte Subsets in the Body
下载PDF
导出
摘要 [目的]通过对急性髓细胞白血病移植患者服用环孢菌素A(cyclosporin A,Cs A)前后外周血淋巴细胞亚群的检测,初步探讨Cs A体内作用2h对淋巴细胞亚群的影响。[方法]采用流式细胞术检测43例急性髓细胞白血病移植后患者的空腹及服用Cs A 2h的外周血T、B淋巴细胞,NK细胞的表达;同时应用化学发光法检测Cs A的浓度。[结果]43例急性髓细胞白血病移植患者空腹Cs A浓度为(125.43±65.94)ng·m L-1,服药2h浓度为(564.46±258.67)ng·m L-1;服药2h与空腹相比,CD3+细胞显著下调而NK细胞显著上升,但CD4+、CD8+、CD19+细胞及CD4+/CD8+却无明显变化。[结论]服用Cs A 2h即能达到体内分布且影响CD3+细胞的数量,尚不能影响B细胞的数量。对于急性髓细胞白血病患者移植后服用Cs A期间,有必要对Cs A的浓度及淋巴细胞亚群进行监测以求达到合适的血药浓度,了解患者机体免疫状况,判断预后。 Objective] By detecting the peripheral blood lymphocyte subsets of AML patients before and after taking cyclosporin A, preliminary discussion on making two hours effects of cyclosporin A on lymphocyte subsets in the body. [Methods] Fasting and taking cyclosporin A two hours of the expression of peripheral blood T, B lymphocytes and NK cel were detected by flow cytometry in 43 cases of patients with AML after transplantation. At the same time, application of chemiluminescence detection concentration of cyclosporin A. [Results] The results of cyclosporin A concentration: Fasting group is 125.43 ±65.94)ng·ml-1. Taking two hours group is 564.46±258.67 ng·ml-1; Taking two hours group compared with the fasting group, CD3+ cel is significantly reduced and NK cel is significantly increased, but CD4+, CD8+, CD19+cel and CD4+/CD8+ have no obvious change. [Conclusions] Taking cyclosporin A 2 hours can achieve distribution and affect the number of CD3+ cel in the body, but can not affect the B cel . To AML patients after transplantation, in order to achieve the appropriate concentration and keep abreast of the body's immune status of patients, it is necessary to monitor the concentration of cyclosporin A and lymphocyte subsets during their taking cyclosporin A, which helps us determine the prognosis.
作者 胡正军
出处 《浙江中医药大学学报》 CAS 2014年第11期1308-1310,共3页 Journal of Zhejiang Chinese Medical University
关键词 淋巴细胞亚群 造血干细胞移植 CsA lymphocyte subsets cyclosporin A hematopoietic stem cel transplantation
  • 相关文献

参考文献7

二级参考文献68

  • 1刘改英,林愈灯.急性淋巴细胞白血病患儿外周血T淋巴细胞免疫功能的研究[J].实用诊断与治疗杂志,2004,18(4):269-270. 被引量:8
  • 2王欣,谈恒山,张晋萍,黄莉莉.肝移植受者应用环孢素A与FK506的药物经济学比较[J].中国医院药学杂志,2006,26(3):324-325. 被引量:2
  • 3Gratwohl A, Brand R, Apperley, et al. Allogeneic hematopoietic stem transplantation for chronic myeloid leukemia in Europe 2006 : transplant activity, long-term data and current results. Analysis by the Chronic Leukemia Working Party of European Group for Blood and Marrow Transplantation ( EBMT ) [J ]. Haematologica ,2006 ,91 (4) :513 - 521.
  • 4Balduzzi A, Valsecchi MG, Uderzo C, et al. Chemotherapy versus allogeneic transplantation for very high-risk childhood acute lymphoblastic leukemia in first complete remission : comparison by genetic randomization in an international prospective study[ J]. Lancet,2005,366 : 635 - 642.
  • 5Guardiola P, Pasquini R, Dokal L, et al. Outcome of 69 allogeneic stem cell transplantation for Fanconi anemia using HLA-matched unrelated donors:a study on behalf of the European Group for Blood and Marrow Transplantation [J]. Blood ,2000,95 ( 2 ) :422 - 429.
  • 6Lazarus HM, Perez WS, Klein JP, et al. Autotransplantation versus HLA-matched unrelated donor transplantation for acute myeloid leukemia: a retrospective analysis from the Center for Intemational Blood and Marrow Transplant Research [ J ]. Br J Haematol,2006,132 ( 6 ) :755 - 769.
  • 7Gaynon PS, Harris RE, Altman AJ, et al. Bone marrow transplantation versus prolonged intensive chemotherapy for children with acute lymphoblastic leukemia and initial bone marrow relapse within 12 months of the completion of primary therapy[J]. J Clin Oncol, 2006, 24(19) :3150-3156.
  • 8Arai S, Klingemann HG. Hematopoietic stem cell transplantation: bone marrow vs mobilized peripheral bllod E J 1. Arch Med Res,2003,34 ( 6 ) :545 - 553.
  • 9Ballen KK. New trend in umbilical cord blood transplantation[J]. Blood,2005,105(10) :3786 -3792.
  • 10Locatelli F, Rocha V, Reed W, et al. Related umbilical cord blood transplantation in patients with thalassemia and silk cell disease[J]. Blood,2003,101(6) :2137 -2143.

共引文献19

同被引文献6

引证文献1

二级引证文献2

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部